Preparing for China · patient guide

Pathology needed for a second opinion in China, explained simply

A pathology second opinion in China is built from your original slides and tissue blocks, not from a summary letter. Ask your pathology laboratory to release representative stained slides, the corresponding paraffin blocks where available, and the full original report. The receiving hospital then decides whether the material is adequate, what additional testing it needs and whether a review can proceed.

Go to the practical guidance ↓
AI illustration: Two women engaged in a conversation at a reception desk in a modern office or clinic setting.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

What a reviewing pathologist actually needs from you

A pathology second opinion is a re-examination of the tissue itself. The reviewer looks down the microscope at the same material your first pathologist examined, then compares that appearance with the original description and with your clinical history. A typed summary of the diagnosis, however detailed, cannot substitute for the slides, because the whole point is to check the interpretation against the tissue.

The core set is therefore three things: the original written pathology report, the stained slides that were used to make the diagnosis, and the paraffin blocks from which those slides were cut. Blocks matter because the reviewing laboratory may need to cut new sections or run additional tests that were not performed the first time. If blocks cannot travel, unstained sections cut onto charged slides are sometimes an alternative, but whether that is acceptable is a laboratory decision, not something to assume.

Ask your laboratory for the material in a way that preserves the diagnostic set. If you request only one or two slides, the reviewer may be unable to assess the tumour margins, the grade or the areas that were borderline in the original reading. A short cover letter from your treating clinician explaining the question being asked is useful context, but it does not replace the report.

It also helps to be clear about what you want answered. A review that confirms or revises a cancer diagnosis is a different task from a review that checks whether a rare tumour was classified correctly, or whether a specimen was adequately sampled. The hospital can tell you whether the material you can supply is sufficient for the question you are asking.

Cancer pathology review

Slides, blocks and reports: how the request is worded

Hospitals and laboratories generally release pathology material on request from the patient or the treating clinician, but the process differs between countries and between institutions. The practical step is to contact the pathology department that issued your report and ask, in writing, what their release procedure is. Some laboratories require a signed authorisation from the patient; some require a request from a clinician; some charge a handling or administrative fee for preparing and posting material.

When you write, name the specific items you want: the original report with any addenda, the haematoxylin and eosin stained slides, the immunohistochemistry slides if any were made, and the paraffin blocks. If the laboratory keeps material in more than one store, ask whether all relevant blocks are included. Ask how the material will be packed and whether tracking is provided.

Keep the original report with the shipment or send a copy ahead of it. The reviewing pathologist needs to know what was sampled, how it was processed and what stains were used. If there were previous biopsies or surgeries at other hospitals, those reports and slides are relevant too, because tumour evolution and earlier treatment can change how a later specimen is interpreted.

Do not send irreplaceable material without agreeing how it will be returned. Slides and blocks are finite; if a block is lost or damaged, further testing may become impossible. Ask the receiving hospital and the releasing laboratory to confirm the return route and who is responsible at each stage.

Shipping pathology material into China: what to confirm first

Pathology material crosses borders as biological material, and the rules that apply depend on what is being sent and by which route. Glass slides and paraffin blocks are not the same as fresh tissue or body fluids, and carriers treat them differently. Rather than relying on general advice, confirm the requirements with the receiving hospital's pathology department and with the courier you intend to use, before anything leaves your laboratory.

The questions worth asking are concrete. Does the receiving hospital accept material sent directly by a patient, or does it require shipment from one laboratory to another? Does it need a declaration describing the contents? Which courier does the hospital's pathology department routinely receive from? What documentation must accompany the package, and who clears it on arrival? Will the hospital store the material until your appointment, and for how long?

Temperature and handling matter less for fixed, paraffin-embedded tissue than for fresh specimens, but packaging still needs to prevent slides from breaking and blocks from being lost. Ask the releasing laboratory to pack to a standard the receiving laboratory recognises, and ask for a packing list inside the parcel.

If direct shipment proves impractical, an alternative is to travel with the material yourself, carrying the original report and a letter from the releasing laboratory. Whether a hospital accepts hand-carried material, and what it needs at reception, is a question for that hospital. Confirm it in writing rather than assuming the answer.

What the review can and cannot settle

A pathology review addresses the tissue diagnosis: what the cells look like, whether the classification is right, whether the specimen was adequate and whether additional stains or molecular tests would change the picture. That is a genuinely useful check, particularly for uncommon tumours, borderline appearances or diagnoses that would lead to very different treatment paths.

It does not by itself decide your treatment. The reviewing pathologist describes the tissue; the treating oncologist or surgeon then integrates that with imaging, your history and your preferences. A review that confirms the original diagnosis is a meaningful result, not a wasted step, because it supports the plan you are considering. A review that disagrees raises the question of which interpretation the treating team will act on, and that discussion belongs with the clinicians responsible for your care.

Some questions cannot be answered from the material available. If the original specimen was small, or if the relevant area was not sampled, no reviewer can create tissue that was never taken. In that situation the hospital may recommend a further biopsy, which is a clinical decision made in China after assessing you, not something a records review can arrange in advance.

Ask the hospital, before shipping, what it will state in its report and whether it will comment on the specific question your treating team has raised. A review that answers a different question from the one you need is of limited value.

Rare and unusual tumours need a different kind of review

For common cancers, a pathology review is usually a focused check of diagnosis, grade and margins. For rare tumours, sarcomas, unusual lymphomas or tumours whose classification has changed in recent years, the review may need input from a pathologist with subspecialty experience, and may involve additional immunohistochemistry or molecular testing on the blocks.

This changes what you should send and what you should ask. A rare-tumour review may need the blocks rather than only the slides, because new tests require tissue. It may need the original report plus any earlier reports, since the differential diagnosis often depends on how the lesion evolved. It may also take longer to arrange, because the relevant expertise and the additional testing have to be coordinated.

Ask whether the hospital's review will involve a pathologist with specific experience in your tumour type, and whether the quoted scope includes additional stains or molecular studies or whether those are arranged and charged separately. The answer affects both what you send and what you should expect from the report.

If your case is complex enough to need several specialties looking at it together, a multidisciplinary review may be the appropriate route. That is a different service from a single pathologist's re-read, and the scope should be agreed before anything is shipped.

Practical preparation and the next step

Before you commit to shipping anything, gather the documents that make the review possible: the original pathology report and any addenda, operative notes if surgery was performed, imaging reports and a short summary of your treatment so far. These let the receiving team judge whether the material you can supply matches the question you are asking.

Then ask the receiving hospital three things in writing: which items it needs for your specific case, how it wants them shipped and returned, and what its report will cover. Confirm whether the hospital's pathology department will deal with you directly or expects correspondence from your laboratory. Keep copies of everything you send, and keep the tracking record.

An initial enquiry to ChinaSpecialistCare is free and does not commit you to buying anything. A brief summary of your diagnosis and your main question is enough to start; the team can identify what is missing and suggest the relevant next step. Whether a review is suitable, what material is adequate and what the report will conclude are decisions for the hospital and its pathologists.

Sources & scope of this guide

References and official service information relevant to this guide.

  1. Cancer pathology review

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.